Archive | Podcast RSS feed for this section

Preparing to Pitch with the End in Mind

14 Apr

By Rory McCann, Marketing Manager & Conference Producer, LSN

Bold Therapeutics is a clinical-stage pharma startup developing and commercializing novel therapeutics to combat drug resistance in cancer and infectious disease. At Digital RESI March, Bold Therapeutics founder Russell McAllister met success at the Innovator’s Pitch Challenge (IPC) and is sharing his perspectives from preparation to pitch to follow-up conversations. If you’re actively fundraising or considering pitching at RESI, check out our conversation and learn how Russell leveraged, not only his company, but his own unique experience to stand out at RESI.

IPC applications are still live until Friday, April 29. Get your application in by Friday, April 15 to save on super early bird rates!

Making a Difference One Impression at a Time

10 Feb

By Rory McCann, Marketing Manager & Conference Producer, LSN

Amplified Sciences CEO and Co-Founder, Diana Caldwell knows a lot about lasting impressions. It was an early impression working with her co-founder, Dr. Jo Davisson that led her to join him in leading Amplified Sciences and advancing the early detection of devastating diseases, such as pancreatic cancer. Additionally, Diana’s recent first-place win at the Digital RESI JPM Innovator’s Pitch Challenge (IPC) was a result of the impressions she left with judges and attendees alike with marketing materials and a live pitch.

Listen to our conversation to learn more about Diana’s career as a pharma executive and how her experience and passion led her to her latest adventure: entrepreneurship, fundraising, changing the diagnostic landscape, and leaving all the right impressions along the way.

The IPC returns to Digital RESI March 22-24. Apply today and save $200 when you register by February 18!


Digital Partnering for Fundraising and Licensing Deals Isn’t Going Anywhere in 2022 – Hear Some Sage Advice from Life Science Nation’s CEO on Global Partnering Initiatives for Your Firm

16 Dec

By Rory McCann, Marketing Manager & Conference Producer, LSN

Virtual fundraising is not dead. It’s alive and well for 2022. In this conversation with LSN CEO, Dennis Ford discusses the virtual fundraising model and how Digital RESI JPM stands out as a vehicle for connecting ideas and capital in early-stage life science and healthcare.

Sign up by December 17 to save up to $200 on Digital RESI JPM!

The Future ETF of Early-Stage Investments

4 Nov

By Rory McCann, Marketing Manager & Conference Producer, LSN

KYTO Technology & Life Science is not your typical investment firm. They have a unique model that focuses on the financial investment, mentorship and advising, as well as growth and success of early-stage life science technology and their founding teams. Tom Vogelsong is the Director of Deal Flow and he sat down to discuss what makes KYTO’s outlook and processes different, the unique value they add to their portfolio, and exciting developments in the works.

KYTO is a frequent attendee and valuable asset to the RESI community. Get to know Tom and the team at Digital RESI November 16-18. Partnering is open, but there’s still time to sign up and book meetings! Register today to jumpstart your fundraising.


Pain Points and the Power of Perseverance: The MindLab Story

28 Oct

By Rory McCann, Marketing Manager & Conference Producer, LSN

Larry Raoul James is no stranger to challenge, rejection, and powering through. His company, MindLab has developed a pain management therapeutic designed to prevent tolerance, dependence, and addiction in patients, while sustaining current efficacy standards. With recent endorsement from the US Army Medical Research & Development Command (a connection made through a recent RESI conference), Larry and the MindLab team are not slowing down. Despite the challenges associated with bringing novel therapeutics to market, they are working hard to meet a persistent and growing need for safe alternatives to pain medication.

Listen to a recent interview with Larry on the MindLab journey.

Tomorrow is the last day to sign up for Digital RESI November 16-18 at early bird rates. Sign up today to get started and save $100!

Automating Cancer Imaging Analysis – Interview with Joe Camaratta, President & CEO of Quantaras

26 Oct

By Erika Wu, Business Development Representative, LSN

Earlier this year, Quantaras (formerly known as Quantitative Radiology Solutions, QRS) received 510(k) clearance from the FDA and is now actively launching their AI-based technology to healthcare providers in the United States. Tune in and learn how Joe Camaratta, President & CEO of Quantaras, and his team are revolutionizing personalized cancer treatment decisions with the automation of medical imaging analysis. Digital RESI November (16-18) returns with dynamic panels, as well as opportunities to pitch to a live panel of investors. Learn more about how you can get involved and tell your story at November’s Innovator’s Pitch Challenge!


AI Diagnostics from Oncology, Cardio, and Beyond – Interview with Jonathan Cohen, JD, Founder & CEO of 20/20 Gene Systems

19 Oct

By Erika Wu, Business Development Representative, LSN

Past RESI AI panelist, Jonathan Cohen returns to give an update on 20/20 Gene Systems, including an expansion from cancer detection to respiratory and cardiovascular diagnostics. Learn how Jonathan and the team are using Artificial Intelligence (AI) to expand their offerings, and how they’re working to create more opportunities for early-stage diagnostic startups. Digital RESI November (16-18th) returns with dynamic panels, as well as opportunities to pitch to a live panel of investors. Learn more about how you can get involved and tell your story at November’s Innovator’s Pitch Challenge!


%d bloggers like this: